| Company/Division name | Teva Pharmaceutical Industries North America |
| Parent company | Teva Pharmaceutical Industries Limited |
| Reshoring category: | Foreign Direct Investment |
| Total number of jobs (added or to be added): | 843 |
| Year reshoring announced: | 2018 |
| Country(ies) from which reshored: | Israel |
| City reshored to: | Parsippany-Troy Hills |
| State(s) reshored to: | NJ |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | pharma |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Government Incentives, Impact on domestic economy, Proximity to customers/market, Skilled workforce availability/training, Under-utilized capacity |
| Government Incentive dollar amount: | 40 |
